Recommendations for Standardization of Tobacco Use Treatment Data
A l'aide d'un groupe de travail multidisciplinaire de 12 experts, la "Cancer Center Cessation Initiative (C3I)" du NCI formule des recommandations pour la mesure de la qualité standardisée, l'évaluation et le développement de programmes de sevrage tabagique
Introduction: Although there is widespread acceptance of the importance of assessing and treating tobacco use in cancer care settings, there is much variation in the documentation and reporting of metrics relevant to tobacco treatment. The Cancer Center Cessation Initiative (C3I), as part of NCI’s Cancer Moonshot, convened a Metrics Standardization Workgroup to develop a data dictionary and make recommendations for standardized quality measurement, program evaluation, and tobacco treatment program development.
Methods: A multidisciplinary workgroup of 12 subject matter experts was convened to deliberate and standardize definitions for tobacco assessment and treatment utilization metrics. Decisions on which data elements to include were informed by clinical guidelines, literature reviews, and workgroup members’ expertise. Consensus was reached when all members agreed that the proposed metric was clear, clinically relevant, and could be abstracted and reported.
Results: The group considered metrics in the following categories: (1) patient identification, screening, and referral, (2) tobacco treatment process metrics, and (3) treatment outcomes. We developed a tobacco screening, referral and engagement workflow, and a data library for the following terms: patient population, screening rate, tobacco use prevalence, referral rate, reach, unsuccessful reach attempts, enrollment, treatment engagement, and counseling dose. Outcome metrics (i.e., varied “quit rate” terms) were collated and defined.
Discussion: The proposed standardized data definitions can be used to improve communication and measure effectiveness for tobacco use treatment, research, operational performance, policy, quality improvement, and guideline development.
Journal of Thoracic Oncology , résumé, 2025